WatchBP.nl: Eenvoudig bloeddruk meten conform de internationale richtlijnen is nu mogelijk – met de nieuwe Microlife WatchBP™ bloeddrukmeters

13.06.08 06:29 Leeftijd: 4 yrs

Eenvoudig bloeddruk meten conform de internationale richtlijnen is nu mogelijk – met de nieuwe Microlife WatchBP™ bloeddrukmeters

The world’s first guideline-based total blood pressure assessment system / developed in collaboration with the European Society of Hypertension (ESH) / three devices for office and out of office (home and 24-hour monitoring) / effortless and guideline- based techniques for the physician.

Berlin/Germany, June 17th 2008 (dk) –

Global market leader Microlife WatchBP AG from Switzerland will introduce the world’s first total blood pressure assessment system Microlife WatchBP™ at a press conference at this year’s joint ISH and ESH meeting in Berlin, Germany.

“This system marks a new era of blood pressure assessment“, promises Ty-Minh Tan, CMO of Microlife Corporation. „The three devices and their analytic `Cardiovascular Risk Assessment´ software are the only system in the world which has been developed to exactly follow European, American and international guidelines (ESH, AHA, WHO)“, Mr. Tan continues. The office device, for example, measures simultaneously blood pressure three times on the left and right arm during the initial examination. And when the patient applies the home device, it automatically takes two measurements with a 60 second pause in between (morning and evening dual measurement). “The WatchBP™ System is the only solution that delivers a guideline-based total blood pressure profile of the patient. Hypertension can thus be accurately diagnosed and treated reliably and cost-effectively according to the recommended guidelines”, Professor George S. Stergiou of the Hypertension Centre at the Third University Department of Medicine at Sotiria Hospital in Athens/Greece, explains the advantages of this innovation.

(Short version)

More than 970 million people worldwide are thought to be suffering from hypertension, but only in about 21 to 25 percent of patients is the disease being adequately managed.(1,2) Globally, an increasing number of studies are showing numerous potential sources of error that arise when a patient is diagnosed and treated based on the conventional assessment.

Reliable measurement: Getting a comprehensive blood pressure profile

Measurements of blood pressure are used as a basis for diagnosis, treatment, epidemiology and research - in spite of the fact that they are influenced by many factors.

“Inaccurate blood pressure measurements may lead to misdiagnosis and inappropriate treatment of hypertension” explains Dr. Thomas Mengden, a specialist in clinical hypertension and cardiovascular diseases at the Department of Internal Medicine, University Clinic Bonn / Germany.

“In several ways, the regular combination of office and out-of-office blood pressure measurements has proved to be a more fruitful practice compared with office measurements alone. This has allowed more accurate prognostic evaluation of patients characterized by different blood pressure levels” says Professor Gianfranco Parati, professor of medicine at S. Luca Hospital in Milan / Italy.

International hypertension societies are increasingly encouraging patients to get more information by measuring at home. “Home monitoring is the most cost effective method and offers the patient the ability to do repeated measurements in his usual environment“, says Tan. “Ambulatory and home monitoring give a better prediction of cardiovascular risk and are needed in many cases”, adds Professor Thomas Pickering, Professor of Medicine and Co-Director of the Behavioral Cardiovascular Health and Hypertension Program at the Columbia Presbyterian Medical Center in New York / USA.

A new era of blood pressure measurement: the WatchBP™ System by Microlife

„Even though international guidelines contain detailed and clear practical instructions on how to measure your blood pressure, they have rarely been fully implemented in practice“, Stergiou explains. „In close collaboration with hypertension experts of the ESH, Microlife Corporation has developed the new WatchBP™-System for guideline-based measurements at the physician’s office and at home.”

Three devices with special Cardiovascular Risk Assessment Software monitor and analyze blood pressure profiles in and out of the office strictly according to European and American guidelines.

The WatchBP Office obtains triplicate automated simultaneous both arms measurements as recommended for the initial visit at the doctor’s office and also allows routine automated electronic or even auscultatory blood pressure measurements.

The WatchBP Home device provides a reliable and unbiased assessment of blood pressure at home using a monitoring schedule strictly as recommended by the guidelines.

The WatchBP O3 allows both home and ambulatory blood pressure monitoring with one device at reasonable cost and has the potential to spread the application of complete out-of-office blood pressure assessment in practice.

“The new WatchBP™ System overcomes many of the shortcomings of the routinely used method for blood pressure assessment and at the same time makes the application of guidelines as simple as pushing a single button”, says Ty-Minh Tan.

(Long version)

About Microlife WatchBP AG
Microlife WatchBP AG is a Swiss company which is part of the Microlife Group. Microlife WatchBP solutions feature the world’s first and only blood pressure measurement devices to embed recommended blood pressure measurement protocols from leading medical societies including the European Society of Hypertension (ESH) and American Heart Association (AHA). By strictly following recommended guidelines, WatchBP devices help address many of the concerns associated with traditional doctor-office blood pressure measurements and reduce physicians’ concerns about the reliability of home blood pressure measurements.

About Microlife
Microlife is a global market leader in the development and manufacture of innovative medical measurement devices for clinical and home use. Areas of competence include blood pressure measurement devices, digital thermometers and peak-flow-metres. The Taiwanese corporation has 2,400 employees worldwide and manufactures more than 35 million devices for its affiliates in Switzerland and the USA and for sales partners around the world. Microlife’s mission lies in the research and development of innovative technologies that allow patients to monitor essential health parameters independently.

References

1) Sharma, A. M., Wittchen, H. U., Kirch, W., Pittrow, D., Ritz, E., Goke, B., Lehnert, H., Tschope, D., Krause, P., Hofler, M., Pfister, H., Bramlage, P., Unger, T. High prevalence and poor control of hypertension in primary care: cross-sectional study. Journal of Hypertension, 2004 (Vol. 22) (No. 3) 479-486

2) Ihab Hajjar, ¬ Jane M Kotchen, Theodore A Kotchen. HYPERTENSION: Trends in Prevalence, Incidence, and Control. Annual Review of Public Health, Vol. 27 (2006), pp. 465-490

This press release can be reproduced free of charge.
Please supply a complimentary copy.

Publisher:
Microlife WatchBP AG
Espenstrasse 139
9443 Widnau / Switzerland www.watchbp.com

Press contact:
Dorothea Küsters Life Science Communications GmbH
Birgit Jaretz
Oberlindau 80-82, 60323 Frankfurt
Phone.: 069 / 61 998-24, Fax: 069 / 61 998-10
E-Mail: jaretz(at)dkcommunications.de

nieuwslijst



WatchBP.nl > Meer informatie > Laatste nieuws > Single

13.06.08 06:29 Leeftijd: 4 yrs Eenvoudig bloeddruk meten conform de internationale richtlijnen is nu mogelijk – met de nieuwe Microlife WatchBP™ bloeddrukmeters The world’s first guideline-based total blood pressure assessment system / developed in collaboration with the European Society of Hypertension (ESH) / three devices for office and out of office (home and 24-hour monitoring) / effortless and guideline- based techniques for the physician. Berlin/Germany, June 17th 2008 (dk) – Global market leader Microlife WatchBP AG from Switzerland will introduce the world’s first total blood pressure assessment system Microlife WatchBP™ at a press conference at this year’s joint ISH and ESH meeting in Berlin, Germany. “This system marks a new era of blood pressure assessment“, promises Ty-Minh Tan, CMO of Microlife Corporation. „The three devices and their analytic `Cardiovascular Risk Assessment´ software are the only system in the world which has been developed to exactly follow European, American and international guidelines (ESH, AHA, WHO)“, Mr. Tan continues. The office device, for example, measures simultaneously blood pressure three times on the left and right arm during the initial examination. And when the patient applies the home device, it automatically takes two measurements with a 60 second pause in between (morning and evening dual measurement). “The WatchBP™ System is the only solution that delivers a guideline-based total blood pressure profile of the patient. Hypertension can thus be accurately diagnosed and treated reliably and cost-effectively according to the recommended guidelines”, Professor George S. Stergiou of the Hypertension Centre at the Third University Department of Medicine at Sotiria Hospital in Athens/Greece, explains the advantages of this innovation. (Short version) More than 970 million people worldwide are thought to be suffering from hypertension, but only in about 21 to 25 percent of patients is the disease being adequately managed.(1,2) Globally, an increasing number of studies are showing numerous potential sources of error that arise when a patient is diagnosed and treated based on the conventional assessment. Reliable measurement: Getting a comprehensive blood pressure profile Measurements of blood pressure are used as a basis for diagnosis, treatment, epidemiology and research - in spite of the fact that they are influenced by many factors. “Inaccurate blood pressure measurements may lead to misdiagnosis and inappropriate treatment of hypertension” explains Dr. Thomas Mengden, a specialist in clinical hypertension and cardiovascular diseases at the Department of Internal Medicine, University Clinic Bonn / Germany. “In several ways, the regular combination of office and out-of-office blood pressure measurements has proved to be a more fruitful practice compared with office measurements alone. This has allowed more accurate prognostic evaluation of patients characterized by different blood pressure levels” says Professor Gianfranco Parati, professor of medicine at S. Luca Hospital in Milan / Italy. International hypertension societies are increasingly encouraging patients to get more information by measuring at home. “Home monitoring is the most cost effective method and offers the patient the ability to do repeated measurements in his usual environment“, says Tan. “Ambulatory and home monitoring give a better prediction of cardiovascular risk and are needed in many cases”, adds Professor Thomas Pickering, Professor of Medicine and Co-Director of the Behavioral Cardiovascular Health and Hypertension Program at the Columbia Presbyterian Medical Center in New York / USA. A new era of blood pressure measurement: the WatchBP™ System by Microlife „Even though international guidelines contain detailed and clear practical instructions on how to measure your blood pressure, they have rarely been fully implemented in practice“, Stergiou explains. „In close collaboration with hypertension experts of the ESH, Microlife Corporation has developed the new WatchBP™-System for guideline-based measurements at the physician’s office and at home.” Three devices with special Cardiovascular Risk Assessment Software monitor and analyze blood pressure profiles in and out of the office strictly according to European and American guidelines. The WatchBP Office obtains triplicate automated simultaneous both arms measurements as recommended for the initial visit at the doctor’s office and also allows routine automated electronic or even auscultatory blood pressure measurements. The WatchBP Home device provides a reliable and unbiased assessment of blood pressure at home using a monitoring schedule strictly as recommended by the guidelines. The WatchBP O3 allows both home and ambulatory blood pressure monitoring with one device at reasonable cost and has the potential to spread the application of complete out-of-office blood pressure assessment in practice. “The new WatchBP™ System overcomes many of the shortcomings of the routinely used method for blood pressure assessment and at the same time makes the application of guidelines as simple as pushing a single button”, says Ty-Minh Tan. (Long version) About Microlife WatchBP AG Microlife WatchBP AG is a Swiss company which is part of the Microlife Group. Microlife WatchBP solutions feature the world’s first and only blood pressure measurement devices to embed recommended blood pressure measurement protocols from leading medical societies including the European Society of Hypertension (ESH) and American Heart Association (AHA). By strictly following recommended guidelines, WatchBP devices help address many of the concerns associated with traditional doctor-office blood pressure measurements and reduce physicians’ concerns about the reliability of home blood pressure measurements. About Microlife Microlife is a global market leader in the development and manufacture of innovative medical measurement devices for clinical and home use. Areas of competence include blood pressure measurement devices, digital thermometers and peak-flow-metres. The Taiwanese corporation has 2,400 employees worldwide and manufactures more than 35 million devices for its affiliates in Switzerland and the USA and for sales partners around the world. Microlife’s mission lies in the research and development of innovative technologies that allow patients to monitor essential health parameters independently. References 1) Sharma, A. M., Wittchen, H. U., Kirch, W., Pittrow, D., Ritz, E., Goke, B., Lehnert, H., Tschope, D., Krause, P., Hofler, M., Pfister, H., Bramlage, P., Unger, T. High prevalence and poor control of hypertension in primary care: cross-sectional study. Journal of Hypertension, 2004 (Vol. 22) (No. 3) 479-486 2) Ihab Hajjar, ¬ Jane M Kotchen, Theodore A Kotchen. HYPERTENSION: Trends in Prevalence, Incidence, and Control. Annual Review of Public Health, Vol. 27 (2006), pp. 465-490 This press release can be reproduced free of charge. Please supply a complimentary copy. Publisher: Microlife WatchBP AG Espenstrasse 139 9443 Widnau / Switzerland www.watchbp.com Press contact: Dorothea Küsters Life Science Communications GmbH Birgit Jaretz Oberlindau 80-82, 60323 Frankfurt Phone.: 069 / 61 998-24, Fax: 069 / 61 998-10 E-Mail: jaretz(at)dkcommunications.de nieuwslijst